MedPath

A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia

Not Applicable
Completed
Conditions
Myopia
Astigmatism
Registration Number
NCT00365677
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

The objective of this study was to compare the safety and effectiveness of two versions of the Bausch \& Lomb Zyoptix Tissue Saving Aspheric Algorithm versus the current Zyoptix Tissue Saving Algorithm when used for myopia and myopic astigmatism LASIK treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
127
Inclusion Criteria
  • Myopia with or without astigmatism.
  • Normal Corneal topography
  • Willing to have both eyes treated with the laser.
Exclusion Criteria
  • Contraindications to LASIK.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Uncorrected visual acuityAt 90 days post surgery
Preservation of best spectacle corrected high contrast logMAR distance visual acuity compared to baseline.At 90 days post surgery
Secondary Outcome Measures
NameTimeMethod
Deviation from target correctionAt 90 days post surgery
Improvement in uncorrected distance high contrast logMAR visual acuity compared to baselineAt 90 days post surgery
© Copyright 2025. All Rights Reserved by MedPath